Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest Cancer Research Stories

2013-12-04 00:21:10

Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and pediatrics partner Seattle Children's Research Institute join together to launch Juno Therapeutics Inc. Company founded with $120M initial investment, among largest fully committed Series A for a biotech startup in history Juno to develop broad pipeline of potentially revolutionary cancer immunotherapy products NEW YORK and SEATTLE, Dec. 4, 2013 /PRNewswire-USNewswire/ -- The Fred Hutchinson Cancer Research...

2013-12-02 21:15:20

Scientists have described a new family of proteins that appear to play a key role in cancer and might be targets for future cancer drugs. A major new study in the journal Nature sets out the structure of the new family, called glutamate intramembrane proteases – the founding member of which plays a critical role in transforming healthy cells into cancer cells. The research, funded by Cancer Research UK and conducted by scientists at The Institute of Cancer Research, London, defined...

2013-11-29 23:23:38

In response to an article published by U.S. News & World Report, Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, discusses a new drug combination that could eradicate glioblastoma. Bohemia, NY (PRWEB) November 29, 2013 Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, responds to an article published by U.S. News & World Report on November 25, 2013 that discusses how a new drug cocktail may...

2013-11-27 23:04:25

Alliance for Cancer Gene Therapy (ACGT) – a Stamford, CT-based non-profit devoted exclusively to treating and eradicating cancer with cell and gene therapies – has provided a $500,000 grant to combat glioblastoma, one of the most difficult types of brain cancer to treat. Visit http://www.ACGTFoundation.org. United States and Canada (PRWEB) November 27, 2013 Alliance for Cancer Gene Therapy (ACGT) – a Stamford, CT-based non-profit devoted exclusively to treating and eradicating...

2013-11-27 15:48:08

Women who are members of families with BRCA2 mutations but who test negative for the family-specific BRCA2 mutations are still at greater risk for developing breast cancer compared with women in the general population, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. Women with certain mutations in their BRCA1 or BRCA2 genes are at increased risk for breast cancer. However, if a woman who comes...

2013-11-23 23:03:40

The Greenville Health System’s Human Performance Laboratory – expected to open in January 2014 – is the first HPL in the nation to be fully embedded into a cancer research and treatment program. Greenville, S.C. (PRWEB) November 23, 2013 The Greenville Health System’s Human Performance Laboratory – expected to open in January 2014 – is the first HPL in the nation to be fully embedded into a cancer research and treatment program. The HPL, which already is working with a...

2013-11-23 23:02:03

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, commends Matt Englander for his determination to embrace life despite his battle with brain cancer. New York, NY (PRWEB) November 23, 2013 Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, commends Matt Englander for his will to live a full life despite his battle with brain cancer. According to a November 13, 2013 article published by ABC News titled...

2013-11-23 23:01:53

A new report published in the Proceedings of the National Academy of Science (PNAS) Early Edition details a study funded in part by the National Foundation for Cancer Research, which indicates magnetic resonance (MR) imaging may be able to discern which patients will benefit more from anti-angiogenic drugs. Bethesda, MD (PRWEB) November 23, 2013 A new report published in the Proceedings of the National Academy of Science (PNAS) Early Edition details a study funded in part by the National...

Study Finds Drug-Resistant Melanoma Treatments May Be Enhanced
2013-11-22 09:27:11

April Flowers for redOrbit.com - Your Universe Online More than 8,000 Americans are killed each year by melanoma -- the deadliest form of skin cancer. The presence of mutations in a gene known as the BRAF gene drives approximately 40 percent of advanced melanoma tumors. New medications, called BRAF inhibitors, have shown an ability to rapidly shrink melanoma tumors, however BRAF-mutated tumors often resist early treatment and only partially respond to BRAF inhibitors, which leaves...

2013-11-21 12:27:04

-- Patients at Cornell, the Palo Alto Medical Foundation, MD Anderson Participate in First Clinical Program to Comprehensively Use Artificial Intelligence -- FRAMINGHAM, Mass., Nov. 21, 2013 /PRNewswire/ -- Berg, a biopharmaceutical company committed to uncovering health solutions through a data-driven, biological research approach, today announced a first-of-its-kind Phase Ib clinical trial with Weill Cornell Medical College, Palo Alto Medical Foundation, and MD Anderson Cancer...